Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Lai Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9013-658X; OpenAlex author ID A5100687376. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. First author DOI 10.1186/s12885-021-08158-z↗
  2. Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis. Co-author DOI 10.2147/cmar.s167103↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 2 shared papers, 2018–2021 · strength 0.24
  2. Lianyu Chen · 2 shared papers, 2018–2021 · strength 0.24
  3. Chien‐shan Cheng · 2 shared papers, 2018–2021 · strength 0.24
  4. Shulin Yu · 1 shared paper, 2021 · strength 0.12
  5. Yawen Geng · 1 shared paper, 2021 · strength 0.12
  6. Chao Qu · 1 shared paper, 2021 · strength 0.12
  7. Zhiqiang Meng · 1 shared paper, 2021 · strength 0.12
  8. Fengjiao Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.